Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doriano Fabbro

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.
Journal of Leukocyte Biology|August 3, 2011
IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivationEmmanouil Kyriakakis, Marco Cavallari, Dennis Pfaff, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277Marc Liniger, Christian Neuhaus, Tatjana Hofmann, et al.
Bone|January 31, 2004
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathwayIrene Recchia, Nadia Rucci, Alessia Funari, et al.
Nature Genetics|April 21, 2004
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemiaYiguo Hu, Yuhua Liu, Shawn Pelletier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivoBarbara Hofstetter, Van Vuong, Angela Broggini-Tenzer, et al.
Cancer Research|June 4, 2008
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFRMichelle Croyle, Nagako Akeno, Jeffrey A Knauf, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2006
Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapyNadia Rucci, Irene Recchia, Adriano Angelucci, et al.
The Journal of Clinical Investigation|June 17, 2004
Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycinJing Chen, Nathan R Wall, Kerry Kocher, et al.
Blood|October 24, 2002
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinasesMarkus Warmuth, Nicola Simon, Olga Mitina, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Cancer Research|September 18, 2004
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemiaJan Cools, Nicole Mentens, Pascal Furet, et al.
Journal of Leukocyte Biology|August 3, 2011
IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivationEmmanouil Kyriakakis, Marco Cavallari, Dennis Pfaff, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277Marc Liniger, Christian Neuhaus, Tatjana Hofmann, et al.
Bone|January 31, 2004
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathwayIrene Recchia, Nadia Rucci, Alessia Funari, et al.
Nature Genetics|April 21, 2004
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemiaYiguo Hu, Yuhua Liu, Shawn Pelletier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivoBarbara Hofstetter, Van Vuong, Angela Broggini-Tenzer, et al.
Cancer Research|June 4, 2008
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFRMichelle Croyle, Nagako Akeno, Jeffrey A Knauf, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2006
Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapyNadia Rucci, Irene Recchia, Adriano Angelucci, et al.
The Journal of Clinical Investigation|June 17, 2004
Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycinJing Chen, Nathan R Wall, Kerry Kocher, et al.
Blood|October 24, 2002
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinasesMarkus Warmuth, Nicola Simon, Olga Mitina, et al.
Pageof 13